July 17, 2020, 12.04 AM

ZURICH, KOMPAS.com – Switzerland’s drugmaker Novartis’ Sandoz division will not charge developing countries any fees for the company’s 15 generic drugs.

The Novartis drugs will be made available in low-income countries to treat symptoms of Covid-19.

Novartis has stated that this decision will last for the duration of the coronavirus pandemic.

The company’s pledge is to provide antibiotics, steroids, and diarrhea pills to 79 countries listed on the World Bank’s low- and lower-middle-income nations.

Read also: Indonesia Eyes Local Covid-19 Vaccine Mass Production by Mid-2021

Novartis’ effort has garnered the attention of non-governmental organization (NGO Doctors Without Borders, that called for greater transparency on drug pricing.

The NGO additionally called the industry to follow Novartis’ “no profiteering” initiatives for new Covid-19 medicines.

Novartis has stated that its supply chain for the production of the medicines to treat symptoms of Covid-19 has not been disrupted.

The company’s Global Health Chief Operating Officer, Lutz Hegemann, told Reuters that Novartis’ program strived to help vulnerable healthcare systems in Africa, Asia, South America, and Eastern Europe from being overloaded.

Read also: Indonesia Seeks Partners for Coronavirus Vaccine Production

Page:


Recommendation
Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Report
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

News
August 16, 2022, 01.24 PM

UN Envoy Makes First Visit to Myanmar

News
August 15, 2022, 09.06 PM

Myanmar Court Sentences Suu Kyi to 6 Years

News
August 12, 2022, 04.41 PM

Researchers Warn of Melting Antarctic Ice Sheet

News
August 8, 2022, 09.07 AM

ASEAN Wraps Up Foreign Ministers Talks

Business
August 5, 2022, 10.13 PM

China Begins to Ship Bullet Trains to Indonesia

Close Ads